World Scientific
Skip main navigation
Close Drawer MenuOpen Drawer Menu

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×
Our website is made possible by displaying certain online content using javascript.
In order to view the full content, please disable your ad blocker or whitelist our website www.worldscientific.com.

System Upgrade on Mon, Jun 21st, 2021 at 1am (EDT)

During this period, the E-commerce and registration of new users may not be available for up to 6 hours.
For online purchase, please visit us again. Contact us at [email protected] for any enquiries.
Free Access

Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19)

    https://doi.org/10.1142/S0192415X2050038XCited by:28
    Next

    Abstract

    The outbreak caused by COVID-19 is causing a major challenge to clinical management and a worldwide threat to public health. So far, there is no specific anti-coronavirus therapy approved for the treatment of COVID-19. Recently, as the efficacy and safety of traditional Chinese medicine (TCM) is widely acknowledged, it has been brought to a crucial status by the public, governments, and World Health Organization (WHO). For a better popularization of TCM, governments have made several advances in regulations and policies for treatment and measures of novel coronavirus pneumonia (NCP). Therefore, on the basis of epidemiology and virology information, we reviewed relevant meta-analysis and clinical studies of anti-coronavirus therapeutics by TCM, in the aspect of mortality, symptom improvement, duration and dosage of corticosteroid, incidence of complications and the like. In addition, we also summarized preclinical rationale for anti-coronavirus activity by TCM in terms of virion assembly and release, as well as viral entry and replication, which could be a useful contribution for figuring out effective Chinese herbal medicine (CHM) for coronavirus, including ingredients from single monomeric compounds, Chinese herbs, Chinese herb extracts and Chinese herb formulas, or potential targets for medicine. We would like to see these relevant studies, ranging from basic researches to clinical application, could provide some idea on effects of CHM to combat COVID-19 or other coronaviruses, and also offer new thinking for the exploration of therapeutic strategies under the guidance of TCM.

    References

    • Bauch, C.T. and T. Oraby . Assessing the pandemic potential of MERS-CoV. Lancet 382: 662–664, 2013. Crossref, Medline, ISI, Google Scholar
    • Bian, Y.J., W.S. Qi, Q.Q. Song, G.S. Li, Y.L. Fu, T.X. D, Z.H. Jiang and Y.H. Wang . Evaluation on effect of integrative medical treatment on quality of life of rehabilitation stage in 85 patients with SARS. Chin. J. Integr. Tradit. West. Med. 23, 658–660, 2003. Google Scholar
    • Chen, C.J., M. Michaelis, H.K. Hsu, C.C. Tsai, K.D. Yang, Y.C. Wu, J. Cinatl, Jr. and H.W. Doerr . Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J. Ethnopharmacol. 120: 108–111, 2008. Crossref, Medline, ISI, Google Scholar
    • Chen, Z.M., J.F. Fu, Q. Shu, Y.H. Chen, C.Z. Hua, F.B. Li, R. Lin, L.F. Tang, T.L. Wang, W. Wang, Y.S. Wang, W.Z. Xu, Z.H. Yang, S. Ye, T.M. Yuan, C.M. Zhang and Y.Y. Zhang . Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J. Pediatr. 2020, https://doi.org/10.1007/s12519-020-00345-5. Crossref, ISI, Google Scholar
    • Cheng, P.W., L.T. Ng, L.C. Chiang and C.C. Lin . Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin. Exp. Pharmacol. Physiol. 33: 612–616, 2006. Crossref, Medline, ISI, Google Scholar
    • Cinatl, J., B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau and H.W. Doerr . Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361: 2045–2046, 2003. Crossref, Medline, ISI, Google Scholar
    • Ho, T.Y., S.L. Wu, J.C. Chen, C.C. Li and C.Y. Hsiang . Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 74: 92–101, 2007. Crossref, Medline, ISI, Google Scholar
    • Jin, Y.H., L. Cai, Z.S. Cheng, H. Cheng, T. Deng, Y.P. Fan, C. Fang, D. Huang, L.Q. Huang, Q. Huang, Y. Han, B. Hu, F. Hu, B.H. Li, Y.R. Li, K. Liang, L.K. Lin, L.S. Luo, J. Ma, L.L. Ma, Z.Y. Peng, Y.B. Pan, Z.Y. Pan, X.Q. Ren, H.M. Sun, Y. Wang, Y.Y. Wang, H. Weng, C.J. Wei, D.F. Wu, J. Xia, Y. Xiong, H.B. Xu, X.M. Yao, Y.F. Yuan, T.S. Ye, X.C. Zhang, Y.W. Zhang, Y.G. Zhang, H.M. Zhang, Y. Zhao, M.J. Zhao, H. Zi, X.T. Zeng, Y.Y. Wang, X.H. Wang , F.T.Z.H.O.W.U.N.C. Management, E.-B.M.C.O.C.I.E. Research Team, Promotive Association for Medical and Health Care. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil. Med. Res. 7: 4, 2020. Crossref, Medline, ISI, Google Scholar
    • Kim, D.E., J.S. Min, M.S. Jang, J.Y. Lee, Y.S. Shin, J.H. Song, H.R. Kim, S. Kim, Y.H. Jin and S. Kwon . Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells. Biomolecules 9: 696, 2019. Crossref, ISI, Google Scholar
    • Kim, J.Y., P.G. Choe, Y. Oh, K.J. Oh, J. Kim, S.J. Park, J.H. Park, H.K. Na and M.D. Oh . The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: Implication for infection prevention and control measures. J. Kor. Med. Sci. 35: e61, 2020. Crossref, Medline, ISI, Google Scholar
    • Kim, J.Y., Y.I. Kim, S.J. Park, I.K. Kim, Y.K. Choi and S.H. Kim . Safe, high-throughput screening of natural compounds of MERS-CoV entry inhibitors using a pseudovirus expressing MERS-CoV spike protein. Int. J. Antimicrob. Agents 52: 730–732, 2018. Crossref, Medline, ISI, Google Scholar
    • Lau, K.M., K.M. Lee, C.M. Koon, C.S. Cheung, C.P. Lau, H.M. Ho, M.Y. Lee, S.W. Au, C.H. Cheng, C.B. Lau, S.K. Tsui, D.C. Wan, M.M. Waye, K.B. Wong, C.K. Wong, C.W. Lam, P.C. Leung and K.P. Fung . Immunomodulatory and anti-SARS activities of Houttuynia cordata. J. Ethnopharmacol. 118: 79–85, 2008. Crossref, Medline, ISI, Google Scholar
    • Li, S.Y., C. Chen, H.Q. Zhang, H.Y. Guo, H. Wang, L. Wang, X. Zhang, S.N. Hua, J. Yu, P.G. Xiao, R.S. Li and X. Tan . Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 67: 18–23, 2005. Crossref, Medline, ISI, Google Scholar
    • Li, Y., S. Li, N. Du, Y. Dong, X.H. Xiao, Y.P. Yang, L. Li, S.Q. Luo and J.Y. Li . Clinical study on treatment of severe acute respiratory syndrome with integrative Chinese and Western medicine approach. Chin. J. Integr. Tradit. West. Med. 24(1): 28–31, 2004. Google Scholar
    • Li, Z.J., F.H. Bao, Q. Li, B.K. Wang, Y.P. Li and J.D. Wang . Clinical study on treatment of severe acute respiratory syndrome with integrated Traditional Chinese and Western medicine. Chin. J. Integr. Tradit. West. Med. Intens. Crit. Care. 10(4): 214–216, 2003. Google Scholar
    • Lin, C.W., F.J. Tsai, C.H. Tsai, C.C. Lai, L. Wan, T.Y. Ho, C.C. Hsieh and P.D. Chao . Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. 68: 36–42, 2005. Crossref, Medline, ISI, Google Scholar
    • Lin, S.C., C.T. Ho, W.H. Chuo, S. Li, T.T. Wang and C.C. Lin . Effective inhibition of MERS-CoV infection by resveratrol. BMC. Infect. Dis. 17: 144, 2017. Crossref, Medline, ISI, Google Scholar
    • Liu, X., M. Zhang, L. He and Y. Li . Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). Cochrane Database Syst. Rev. 10: CD004882, 2012. Medline, Google Scholar
    • Lu, R., X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, W. Wang, H. Song, B. Huang, N. Zhu, Y. Bi, X. Ma, F. Zhan, L. Wang, T. Hu, H. Zhou, Z. Hu, W. Zhou, L. Zhao, J. Chen, Y. Meng, J. Wang, Y. Lin, J. Yuan, Z. Xie, J. Ma, W.J. Liu, D. Wang, W. Xu, E.C. Holmes, G.F. Gao, G. Wu, W. Chen, W. Shi and W. Tan . Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 395: 565–574, 2020. Crossref, Medline, ISI, Google Scholar
    • Luo, H., Q.L. Tang, Y.X. Shang, S.B. Liang, M. Yang, N. Robinson and J.P. Liu . Can chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin. J. Integr. Med. 26(4): 243–25, 2020. Crossref, Medline, ISI, Google Scholar
    • Luo, W., X. Su, S. Gong, Y. Qin, W. Liu, J. Li, H. Yu and Q. Xu . Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. Biosci. Trends 3: 124–126, 2009. Medline, ISI, Google Scholar
    • NHC. Notice on the novel coronavirus infection diagnosis and treatment plan (trial version four). 2020a, http://www.nhc.gov.cn/yzygj/s7653p/202001/4294563ed35b43209b31739bd0785e67.shtml2020. Google Scholar
    • NHC. Notice on the novel coronavirus infection diagnosis and treatment plan (trial version sixth). 2020b, http://www.gov.cn/zhengce/zhengceku/2020-02/19/content_5480948.htm2020. Google Scholar
    • NHC. Notice on the novel coronavirus infection diagnosis and treatment plan (trial version three). 2020c, http://www.nhc.gov.cn/xcs/yqfkdt/202001/f492c9153ea9437bb587ce2ffcbee1fa.shtml. Google Scholar
    • Park, J.Y., J.H. Kim, Y.M. Kim, H.J. Jeong, D.W. Kim, K.H. Park, H.J. Kwon, S.J. Park, W.S. Lee and Y.B. Ryu . Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg. Med. Chem. 20: 5928–5935, 2012. Crossref, Medline, Google Scholar
    • Ren, A.M., S.W. Zhang, B.E. Wang, L.G. Liu and X.M. Liang . Clinical study on treatment of severe acure respiratory syndrome by intergrative Chinese and Western Medicine. Chin. J. Integr. Tradit. West. Med. 24(3): 112–114, 2004. Google Scholar
    • Ren, L.L., Y.M. Wang, Z.Q. Wu, Z.C. Xiang, L. Guo, T. Xu, Y.Z. Jiang, Y. Xiong, Y.J. Li, X.W. Li, H. Li, G.H. Fan, X.Y. Gu, Y. Xiao, H. Gao, J.Y. Xu, F. Yang, X.M. Wang, C. Wu, L. Chen, Y.W. Liu, B. Liu, J. Yang, X.R. Wang, J. Dong, L. Li, C.L. Huang, J.P. Zhao, Y. Hu, Z.S. Cheng, L.L. Liu, Z.H. Qian, C. Qin, Q. Jin, B. Cao and J.W. Wang . Identification of a novel coronavirus causing severe pneumonia in human: A descriptive study. Chin. Med. J. (Engl.) 2020, https://doi.org/10.1097/CM9.0000000000000722. Crossref, ISI, Google Scholar
    • Ryu, Y.B., H.J. Jeong, J.H. Kim, Y.M. Kim, J.Y. Park, D. Kim, T.T. Nguyen, S.J. Park, J.S. Chang, K.H. Park, M.C. Rho and W.S. Lee . Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition. Bioorg. Med. Chem. 18: 7940–7947, 2010. Crossref, Medline, ISI, Google Scholar
    • Schwarz, S., K. Wang, W. Yu, B. Sun and W. Schwarz . Emodin inhibits current through SARS-associated coronavirus 3a protein. Antiviral Res. 90: 64–69, 2011. Crossref, Medline, ISI, Google Scholar
    • Wen, C.C., L.F. Shyur, J.T. Jan, P.H. Liang, C.J. Kuo, P. Arulselvan, J.B. Wu, S.C. Kuo and N.S. Yang . Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. J. Tradit. Complement. Med. 1: 41–50, 2011. Crossref, Medline, Google Scholar
    • Weng, J.R., C.S. Lin, H.C. Lai, Y.P. Lin, C.Y. Wang, Y.C. Tsai, K.C. Wu, S.H. Huang and C.W. Lin . Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63. Virus Res. 273: 197767, 2019. Crossref, Medline, ISI, Google Scholar
    • WHO. Case definitions for surveillance of severe acute respiratory syndrome (SARS). 2004, http://www.who.int/csr/sars/casedefinition/en. Google Scholar
    • WHO. MERS situation update. 2019, http://www.emro.who.int/pandemic-epidemic-diseases/mers-cov/mers-situation-update-november-2019.html. Google Scholar
    • Wu, C.Y., J.T. Jan, S.H. Ma, C.J. Kuo, H.F. Juan, Y.S. Cheng, H.H. Hsu, H.C. Huang, D. Wu, A. Brik, F.S. Liang, R.S. Liu, J.M. Fang, S.T. Chen, P.H. Liang and C.H. Wong . Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc. Natl. Acad. Sci. USA 101: 10012–10017, 2004. Crossref, Medline, ISI, Google Scholar
    • Yi, W.L. An experimental study on the effect of Shuang-huang-lian, herba Houttuyniae and Allitridin against Murine Hepatitis Virus type 3 in vitro and in vivo Huazhong University of Science and Technology, 2006. Google Scholar
    • Zhu, N., D. Zhang, W. Wang, X. Li, B. Yang, J. Song, X. Zhao, B. Huang, W. Shi, R. Lu, P. Niu, F. Zhan, X. Ma, D. Wang, W. Xu, G. Wu, G.F. Gao, W. Tan , I. China Novel Coronavirus and T. Research. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382: 727–733, 2020. Crossref, Medline, ISI, Google Scholar
    • Zhu, S.Y., X.Y. Li, Y.L. Wei, P.Y. Yang and E.D. Qin . Inhibitory effects of three prescriptions of tradition Chinese medicine on SARS-associated coronavirus in vitro. Lett. Biotechnol. 390–392, 2003. Google Scholar
    • Zu, Z.Y., M.D. Jiang, P.P. Xu, W. Chen, Q.Q. Ni, G.M. Lu and L.J. Zhang . Coronavirus disease 2019 (COVID-19): A perspective from China. Radiology 200490, 2020, https://doi.org/10.1148/radiol.2020200490. Crossref, Medline, Google Scholar
    Published: 29 April 2020
    Remember to check out the Most Cited Articles!

    Check out our Chinese Medicine Titles today.
    Includes titles by Nobel Winner, Tu You You and more!